• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA 24 GA X 3/4 IN SINGLE PORT; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA 24 GA X 3/4 IN SINGLE PORT; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383511
Device Problem Difficult or Delayed Activation (2577)
Patient Problems No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/20/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that nexiva 24 ga x 3/4 in single port needle disengagement was difficult.The following information was provided by the initial reporter: during operation check before catheter placement, the hcp felt a strong resistance when withdrawing the needle.
 
Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: 2021-02-01.H6: investigation summary: bd received a 24 gauge nexiva unit from lot 0163980 for evaluation.A review of the device history record was performed for the reported defect and no quality issues were found during production.Our quality engineer visually inspected the returned unit and observed no damage to the v-clip, grip or retaining washer that could have contributed to the reported issue.During manufacturing this type of defect can result from the process of placing the retaining washer if the washer was inserted incorrectly so that it was not able to float inside the tip shield, from mis-inserted cannula, or from misplaced adhesive.None of these were observed in the unit.Manufacturing operators perform in process sampling and functional testing for retraction throughout the manufacturing process.Functional testing was performed for the returned, while pulling the needle grip assembly back through the catheter there were no signs of drag and resistance experienced.The retaining washer moved freely as it was intended to during retraction and the needle tip was secured within the tip shield.Therefore, the defect of needle disengagement difficult was not observed or confirmed.Since the reported issue was not observed a probable root cause could not be determined.
 
Event Description
It was reported that nexiva 24 ga x 3/4 in single port needle disengagement was difficult.The following information was provided by the initial reporter: during operation check before catheter placement, the hcp felt a strong resistance when withdrawing the needle.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXIVA 24 GA X 3/4 IN SINGLE PORT
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key11335891
MDR Text Key232168742
Report Number1710034-2021-00113
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903835119
UDI-Public00382903835119
Combination Product (y/n)N
PMA/PMN Number
K183399
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 04/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date05/31/2023
Device Catalogue Number383511
Device Lot Number0163980
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2021
Initial Date Manufacturer Received 01/20/2021
Initial Date FDA Received02/16/2021
Supplement Dates Manufacturer Received04/21/2021
Supplement Dates FDA Received05/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-